Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
209.5 USD | -1.40% | -2.48% | -11.39% |
Jun. 13 | Baird Adjusts Price Target on Charles River Laboratories International to $271 From $270 | MT |
Jun. 07 | The job report just threw a spanner in the works |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.39% | 10.79B | |
+40.80% | 53.67B | |
+35.79% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- Insider Buy: Charles River Laboratories International